You searched for: bronchiseptica (Engelska - Estniska)

bordetella bronchiseptica cells.
bordetella bronchiseptica surmatud rakke tiiter2

bordetella bronchiseptica (n=50)
bordetella bronchiseptica (n = 50)

pasteurella multocida and bordetella bronchiseptica
pasteurella multocida ja bordetella bronchiseptica.

titre1 inactivated b. bronchiseptica cells
- ≥ 4. 2 log 2 aggl. tiiter1 bordetella bronchiseptica surmatud rakke

106.3- 108.3 cfu/dose b. bronchiseptica
106,3 -108,3 cfu/ b. bronchiseptica doosis

to stimulate active immunity against bordetella bronchiseptica.
bordetella bronchiseptica vastase aktiivse immuunsuse stimuleerimiseks.

≥ 106,3 and ≤ 108,3 cfu/ dose b. bronchiseptica
≥106, 3 ja ≤108, 3 cfu / b. bronchiseptica doosis

bordetella bronchiseptica is inherently insensitive to ceftiofur in vitro.
bordatella bronchiseptica ei ole in vitro tseftiofuuri suhtes tundlik.

 5.5 log2 agglutination titre2 inactivated bordetella bronchiseptica cells
aglutinatsioonitiitrit2 inaktiveeritud bordetella bronchiseptica rakke

live vaccine against feline upper respiratory tract disease caused by bordetella bronchiseptica.
bordetella bronchiseptica põhjustatud kasside ülemiste hingamisteede haiguse vastane elusvaktsiin.

pseudomonas spp., enterococcus spp., and bordetella bronchiseptica isolates are inherently resistant to cefovecin.
pseudomonas spp., enterococcus spp, ja bordetella bronchiseptica isolaadid omavad loomulikku resistentsust tsefovetsiinile.

colonisation of the surface of the nasal mucosa by pasteurella multocida is most often promoted by bordetella bronchiseptica.
pasteurella multocida koloniseerumisega nina limaskesta pinnal kaasneb sageli bordetella bronchiseptica nakkus.

the vaccine contains a non-toxic recombinant derivative of the pasteurella multocida toxin and inactivated bordetella bronchiseptica cells.
vaktsiin sisaldab mittetoksilist pasteurella multocida toksiini rekombinantset derivaati ja inaktiveeritud bordetella bronchiseptica rakke.

vaccinated animals can spread the vaccine strain of bordetella bronchiseptica for six weeks, and there may be intermittent shedding for at least one year.
vaktsineeritud loomad võivad olla vaktsiinist pärineva bordetella bronchiseptica tüve levitajateks 6 nädalat, võib esineda korduv lühiajaline levitamine vähemalt 1 aasta.

for active immunisation of cats, of 1 month of age or older to reduce clinical signs of bordetella bronchiseptica associated upper respiratory tract disease.
Ühe kuu vanuste ja vanemate kasside aktiivseks immuniseerimiseks bordetella bronchiseptica põhjustatud ülemiste hingamisteede haiguste kliiniliste tunnuste vähendamiseks.

106.3-108.3 colony forming units (cfu) of live bordetella bronchiseptica strain b-c2
106,3 - 108,3 kolooniaid moodustavat ühikut cfu elusat bordetella bronchiseptica tüve b-c2.

106.3-108.3 colony forming units (cfu) of live bordetella bronchiseptica bacteria strain b-c2
106,3 - 108,3 kolooniaid moodustavat ühikut (cfu) elusat bordetella bronchiseptica bakterit, tüve b- c2.

treatment and metaphylaxis of swine respiratory disease associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica sensitive to tulathromycin.
tulatromütsiini suhtes tundlike actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae , haemophilus parasuis’i ja bordetella bronchiseptica’ga seotud sigade respiratoorhaiguse (srd) ravi ja metafülaktika.

in the pivotal clinical trial, the presence of p. multocida and b. bronchiseptica was clearly demonstrated in sick pigs, however no post treatment sampling was done to show bacteriological cure.
otsustava tähtsusega kliinilises uuringus tõendati selgesti p. multocida ja b. bronchiseptica olemasolu haigetel sigadel, kuigi bakterioloogilise paranemise tõendamiseks ravijärgseid proove ei võetud.

treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica and haemophilus parasuis sensitive to tildipirosin.
tildipirosiini suhtes tundlike actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica ja haemophilus parasuis’ga seotud sigade respiratoorhaiguse (srd) ravi ja metafülaktika.